XML 42 R28.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SEGMENT REPORTING (Tables)
6 Months Ended
Jun. 30, 2024
Segment Reporting [Abstract]  
SCHEDULE OF OPERATIONS, ASSETS AND CAPITAL EXPENDITURES FOR OUR BUSINESS SEGMENTS

The following tables reflect results of operations, Segment EBITDA, segmented assets, and expenditures for long-lived assets for our reportable segments for the periods indicated below:

 

 

   Sanara Surgical   THP   Total   Sanara Surgical   THP   Total 
   Three Months Ended 
   June 30, 
   2024   2023 
   Sanara Surgical   THP   Total   Sanara Surgical   THP   Total 
                         
Net revenue  $20,158,823   $-   $20,158,823   $15,753,164   $-   $15,753,164 
Gross profit   18,150,137    -    18,150,137    13,565,648    -    13,565,648 
Selling, general and administrative expenses   18,349,924    607,684    18,957,608    13,301,230    510,246    13,811,476 
Research and development   582,443    403,208    985,651    208,727    968,401    1,177,128 
Depreciation and amortization   698,407    407,100    1,105,507    396,597    407,097    803,694 
Interest expense   644,346    -    644,346    -    -    - 
Net income (loss)   (2,214,313)   (1,314,889)   (3,529,202)   95,098    (1,961,278)   (1,866,180)
Segment EBITDA   1,393,959    (801,778)   592,181    1,120,207    (1,415,831)   (295,624)
                               
Segment assets (at period end) (1)  $51,469,137   $21,914,468   $73,383,605   $51,147,589   $22,723,560   $73,871,149 
Expenditures for long-lived assets  $58,762   $-   $58,762   $12,945   $-   $12,945 

 

   Sanara Surgical   THP   Total   Sanara Surgical   THP   Total 
   Six Months Ended 
   June 30, 
   2024   2023 
   Sanara Surgical   THP   Total   Sanara Surgical   THP   Total 
                         
Net revenue  $38,695,461   $-   $38,695,461   $31,272,351   $2,730   $31,275,081 
Gross profit   34,796,729    -    34,796,729    26,968,141    (6,235)   26,961,906 
Selling, general and administrative expenses   34,032,964    1,116,903    35,149,867    25,768,626    1,011,919    26,780,545 
Research and development   1,161,424    770,525    1,931,949    443,963    2,050,489    2,494,452 
Depreciation and amortization   1,396,908    814,019    2,210,927    768,616    813,953    1,582,569 
Interest expense   911,682    -    911,682    6    -    6 
Net income (loss)   (2,691,798)   (2,636,447)   (5,328,245)   614,061    (3,696,570)   (3,082,509)
Segment EBITDA   2,532,145    (1,628,543)   903,602    2,365,280    (2,953,734)   (588,454)
                               
Segment assets (at period end) (1)  $51,469,137   $21,914,468   $73,383,605   $51,147,589   $22,723,560   $73,871,149 
Expenditures for long-lived assets  $124,580   $-   $124,580   $40,650   $-   $40,650 

 

(1)- Segment assets for 2023 represent assets as of 12.31.23.

 

The following tables provide a reconciliation of net income (loss) to Segment EBITDA for our reportable segments for the periods indicated below:

 

   Sanara Surgical   THP   Total   Sanara Surgical   THP   Total 
   Three Months Ended 
   June 30, 
   2024   2023 
   Sanara Surgical   THP   Total   Sanara Surgical   THP   Total 
Net Income (Loss)  $(2,214,313)  $(1,314,889)  $(3,529,202)  $95,098   $(1,961,278)  $(1,866,180)
Adjustments:                              
Interest expense   644,346    -    644,346    -    -    - 
Depreciation and amortization   698,407    407,100    1,105,507    396,597    407,097    803,694 
Noncash share-based compensation   1,046,321    36,429    1,082,750    1,064,516    62,816    1,127,332 
Change in fair value of earnout liabilities   89,330    (103,103)   (13,773)   (436,004)   75,534    (360,470)
Executive separation costs(1)   904,780    -    904,780    -    -    - 
Acquisition costs   225,088    172,685    397,773    -    -    - 
Segment EBITDA  $1,393,959   $(801,778)  $592,181   $1,120,207   $(1,415,831)  $(295,624)

 

   Sanara Surgical   THP   Total   Sanara Surgical   THP   Total 
   Six Months Ended 
   June 30, 
   2024   2023 
   Sanara Surgical   THP   Total   Sanara Surgical   THP   Total 
Net Income (Loss)  $(2,691,798)  $(2,636,447)  $(5,328,245)  $614,061   $(3,696,570)  $(3,082,509)
Adjustments:                              
Interest expense   911,682    -    911,682    6    -    6 
Depreciation and amortization   1,396,908    814,019    2,210,927    768,616    813,953    1,582,569 
Noncash share-based compensation   1,799,936    86,200    1,886,136    1,609,729    114,908    1,724,637 
Change in fair value of earnout liabilities   (14,451)   (65,000)   (79,451)   (627,132)   (186,025)   (813,157)
Executive separation costs(1)   904,780    -    904,780    -    -    - 
Acquisition costs   225,088    172,685    397,773    -    -    - 
Segment EBITDA  $2,532,145   $(1,628,543)  $903,602   $2,365,280   $(2,953,734)  $(588,454)

 

(1)- Includes $328,795 of share-based compensation related to executive separation costs.